Exosomal LncRNA UCA1 Modulates Cervical Cancer Stem Cell Self-renewal and Differentiation Through MicroRNA-122-5p/SOX2 Axis
Overview
General Medicine
Affiliations
Background: There is growing evidence discussing the role of long non-coding RNAs (lncRNAs) in cervical cancer (CC). We performed this study to explore the impact of exosomal lncRNA urothelial cancer-associated 1 (UCA1) in CC stem cells by sponging microRNA-122-5p (miR-122-5p) and regulating SOX2 expression.
Methods: CC stem cells (CD133CaSki) and exosomes were extracted and identified. The synthesized UCA1- and miR-122-5p-related sequences were transfected into CaSki cells, CaSki cells-derived exosomes were extracted and then co-cultured with CD133CaSki cells. The functional roles of UCA1 and miR-122-5p in self-renewal and differentiation ability of CC stem cells were determined using ectopic expression, knockdown/depletion and reporter assay experiments. An in vivo experiment was performed to verify the in vitro results.
Results: Up-regulated UCA1 and SOX2 and down-regulated miR-122-5p were found in CaSki-Exo. Exosomes promoted invasion, migration, proliferation and restrained apoptosis of CD133CaSki cells. Silencing UCA1 or up-regulating miR-122-5p degraded SOX2 expression, and reduced invasion, migration and proliferation of CD133CaSki cells while advanced apoptosis and suppressed the tumor volume and weight in nude mice.
Conclusion: Our study provides evidence that CaSki-Exo can promote the self-renewal and differentiation ability of CC stem cells while silencing UCA1 or up-regulating miR-122-5p restrains self-renewal and differentiation of CC stem cells.
The role of tumor-derived exosomal LncRNA in tumor metastasis.
Yu Z, Fu J, Mantareva V, Blazevic I, Wu Y, Wen D Cancer Gene Ther. 2025; .
PMID: 40011710 DOI: 10.1038/s41417-024-00852-x.
Patel D, Thankachan S, Sreeram S, Kavitha K, Kabekkodu S, Suresh P Mol Biol Rep. 2025; 52(1):110.
PMID: 39775991 DOI: 10.1007/s11033-024-10215-2.
Advances and challenges in the use of liquid biopsy in gynaecological oncology.
Zhang Y, Tian L Heliyon. 2024; 10(20):e39148.
PMID: 39492906 PMC: 11530831. DOI: 10.1016/j.heliyon.2024.e39148.
Su J, Zhao Y, Chen W, Wang Y Int J Mol Sci. 2024; 25(16).
PMID: 39201624 PMC: 11354701. DOI: 10.3390/ijms25168932.
Yang J, Zhang L, Zhu B, Wu H, Peng M Sci Rep. 2024; 14(1):18500.
PMID: 39122807 PMC: 11316077. DOI: 10.1038/s41598-024-68859-w.